Therefore, although data regarding the effects of cysteamine on the inflammatory status of cystinotic patients and of Ctns−/− mice are lacking, it is conceivable that in cystinosis the efficacy of cysteamine may also be due, in addition to the lowering of intracellular levels of cystine, to an alternative anti-inflammatory mechanism of action. This evidence concerns the gene CTNS and cystinosis.